First human test of new ALS drug begins
Disease control
Completed
This was an early, small study to see how safe a single dose of a new drug called QRL-101 is for people with ALS and to measure how the body absorbs and processes it. Twelve participants with ALS received either the drug or a placebo. The main goal was to gather initial safety da…
Phase: PHASE1 • Sponsor: QurAlis Corporation • Aim: Disease control
Last updated Apr 02, 2026 06:12 UTC